Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

Read more breaking news


News in brief

GSK may move for 51% of Shantha



UK drug major GSK is considering a bid for a 51 per cent share of India’s Shantha Biotech after European rival Sanofi Aventis pulled out of an acquisition deal last week, according to India’s Economic Times.


The newspaper reported that Sanofi had halted talks with Shantha’s majority shareholder, fellow French group the Merieux Alliance, after deciding the Indian biotech’s pipeline was not an attractive enough proposition.

While neither GlaxoSmithKline (GSK) nor the Merieux Alliance have issued a comment, the paper suggests that a deal would help the UK firm bolster its vaccine pipeline through the addition of Shantha’s penatvalents range.

Key Industry Events


Access all events listing

Our events, Events from partners...


Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions